Two Sigma Advisers’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-93,600
| Closed | -$70.2K | – | 2480 |
|
|
2024
Q2 | $70.2K | Sell |
93,600
-3,500
| -4% | -$2.63K | ﹤0.01% | 2339 |
|
|
2024
Q1 | $103K | Sell |
97,100
-12,900
| -12% | -$13.7K | ﹤0.01% | 2302 |
|
|
2023
Q4 | $116K | Sell |
110,000
-21,900
| -17% | -$23K | ﹤0.01% | 2311 |
|
|
2023
Q3 | $148K | Sell |
131,900
-59,289
| -31% | -$66.4K | ﹤0.01% | 2153 |
|
|
2023
Q2 | $288K | Sell |
191,189
-213,811
| -53% | -$322K | ﹤0.01% | 1991 |
|
|
2023
Q1 | $632K | Sell |
405,000
-23,800
| -6% | -$37.1K | ﹤0.01% | 1845 |
|
|
2022
Q4 | $273K | Sell |
428,800
-30,900
| -7% | -$19.7K | ﹤0.01% | 2096 |
|
|
2022
Q3 | $611K | Sell |
459,700
-51,000
| -10% | -$67.8K | ﹤0.01% | 1757 |
|
|
2022
Q2 | $1.13M | Buy |
510,700
+4,400
| +0.9% | +$9.77K | ﹤0.01% | 1529 |
|
|
2022
Q1 | $3.13M | Sell |
506,300
-10,400
| -2% | -$64.4K | 0.01% | 1020 |
|
|
2021
Q4 | $6.52M | Buy |
516,700
+478,200
| +1,242% | +$6.04M | 0.02% | 656 |
|
|
2021
Q3 | $3.53M | Buy |
38,500
+29,100
| +310% | +$2.67M | 0.01% | 954 |
|
|
2021
Q2 | $498K | Sell |
9,400
-1,800
| -16% | -$95.4K | ﹤0.01% | 1936 |
|
|
2021
Q1 | $404K | Buy |
11,200
+1,300
| +13% | +$46.9K | ﹤0.01% | 2095 |
|
|
2020
Q4 | $275K | Buy |
+9,900
| New | +$275K | ﹤0.01% | 2070 |
|